ロード中...

Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions?

To improve cardiovascular outcomes, dyslipidemia in patients with diabetes needs to be treated. Thus, these patients are likely to take glimepiride and rosuvastatin concomitantly. Therefore, this study aimed to evaluate the pharmacokinetic (PK) interactions between these two drugs in healthy males a...

詳細記述

保存先:
書誌詳細
出版年:Drug Des Devel Ther
主要な著者: Kim, Choon Ok, Oh, Eun Sil, Kim, Hohyun, Park, Min Soo
フォーマット: Artigo
言語:Inglês
出版事項: Dove Medical Press 2017
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5330189/
https://ncbi.nlm.nih.gov/pubmed/28260863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S129586
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!